ATE358130T1 - Bicyclische (1,2,4ö-triazol adenosin a2a rezeptor antagonisten - Google Patents

Bicyclische (1,2,4ö-triazol adenosin a2a rezeptor antagonisten

Info

Publication number
ATE358130T1
ATE358130T1 AT02789893T AT02789893T ATE358130T1 AT E358130 T1 ATE358130 T1 AT E358130T1 AT 02789893 T AT02789893 T AT 02789893T AT 02789893 T AT02789893 T AT 02789893T AT E358130 T1 ATE358130 T1 AT E358130T1
Authority
AT
Austria
Prior art keywords
adenosine
triazole
bicyclic
receptor antagonists
antagonists
Prior art date
Application number
AT02789893T
Other languages
English (en)
Inventor
Bernard R Neustadt
Hong Liu
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of ATE358130T1 publication Critical patent/ATE358130T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT02789893T 2001-11-30 2002-11-26 Bicyclische (1,2,4ö-triazol adenosin a2a rezeptor antagonisten ATE358130T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33438501P 2001-11-30 2001-11-30

Publications (1)

Publication Number Publication Date
ATE358130T1 true ATE358130T1 (de) 2007-04-15

Family

ID=23306955

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02789893T ATE358130T1 (de) 2001-11-30 2002-11-26 Bicyclische (1,2,4ö-triazol adenosin a2a rezeptor antagonisten

Country Status (18)

Country Link
US (2) US6875772B2 (de)
EP (1) EP1453836B1 (de)
JP (2) JP4429724B2 (de)
KR (1) KR20050044600A (de)
CN (1) CN1688581A (de)
AR (1) AR037681A1 (de)
AT (1) ATE358130T1 (de)
AU (1) AU2002352933A1 (de)
CA (1) CA2468658C (de)
DE (1) DE60219196T2 (de)
ES (1) ES2283625T3 (de)
HU (1) HUP0402324A3 (de)
IL (1) IL161573A0 (de)
MX (1) MXPA04005158A (de)
PE (1) PE20030653A1 (de)
TW (1) TW200300689A (de)
WO (1) WO2003048163A1 (de)
ZA (1) ZA200404168B (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20030739A1 (es) 2001-11-30 2003-08-28 Schering Corp Antagonistas del receptor de adenosina a2a
IL161573A0 (en) * 2001-11-30 2004-09-27 Schering Corp [1,2,4]-TRIAZOLE BICYCLIC ADENOSINE A2a RECEPTOR ANTAGONISTS
NZ535169A (en) * 2002-03-12 2006-03-31 Wyeth Corp Process for making chiral 1,4-disubstituted piperazines
US20060058320A1 (en) * 2002-09-24 2006-03-16 Kyowa Hakko Kogyo Co., Ltd. [1,2,4] Triazolo[1,5-c]pyrimidine derivatives
TWI331036B (en) * 2002-12-19 2010-10-01 Schering Corp Adenosine a2a receptor antagonists for the treatment of extra-pyramidal syndrome and other movement disorders
WO2004092170A2 (en) 2003-04-09 2004-10-28 Biogen Idec Ma Inc. Triazolotriazines and pyrazolotriazines useful as a2a adenosine receptor antagon ists
ATE418555T1 (de) 2003-04-09 2009-01-15 Biogen Idec Inc A2a-adenosinrezeptorantagonisten
US20070010522A1 (en) * 2003-04-09 2007-01-11 Chi Vu Triazolo[1,5-c]pyrimidines and pyrazolo[1,5-c]pyrimidines useful as a2a adenosine receptor antagonists
US7674791B2 (en) 2003-04-09 2010-03-09 Biogen Idec Ma Inc. Triazolopyrazines and methods of making and using the same
TW200507850A (en) 2003-07-25 2005-03-01 Kyowa Hakko Kogyo Kk Pharmaceutical composition
JPWO2006129626A1 (ja) * 2005-05-30 2009-01-08 協和醗酵工業株式会社 ［１，２，４］トリアゾロ［１，５−ｃ］ピリミジン誘導体の製造法
EP1902716A4 (de) * 2005-06-07 2009-05-13 Kyowa Hakko Kirin Co Ltd Prophylaktisches und/oder therapeutisches mittel für motorische störungen
EP1896415A1 (de) * 2005-06-08 2008-03-12 NeuroSearch A/S Neuartige n-phenyl-piperidinderivate und ihre verwendung als monoamin-neurotransmitter-wiederaufnahmehemmer
WO2007027987A2 (en) 2005-09-02 2007-03-08 Mount Cook Biosciences, Inc. Method of treating parkinson's disease with diarylmethylpiperazine compounds exhibiting delta receptor agonist activity
ES2273599B1 (es) 2005-10-14 2008-06-01 Universidad De Barcelona Compuestos para el tratamiento de la fibrilacion auricular.
US7615556B2 (en) * 2006-01-27 2009-11-10 Bristol-Myers Squibb Company Piperazinyl derivatives as modulators of chemokine receptor activity
US20110064671A1 (en) 2008-03-10 2011-03-17 Cornell University Modulation of blood brain barrier permeability
WO2010008775A1 (en) * 2008-06-23 2010-01-21 Ligand Pharmaceuticals Inc. Aminopyridopyrazinone derivatives for treating neurodegenerative diseases
GB201214106D0 (en) * 2012-08-07 2012-09-19 Univ Strathclyde Immunomodulatory compounds
WO2017173067A1 (en) 2016-03-31 2017-10-05 Versi Group, Llc Delta opioid agonist, mu opioid antagonist compositions and methods for treating parkinson's disease
CN106866582A (zh) * 2017-01-10 2017-06-20 广州隽沐生物科技有限公司 一种氟班色林中间体的制备方法
CN111164084B (zh) 2018-06-26 2023-05-23 浙江春禾医药科技有限公司 可用作a2a受体拮抗剂的三唑并三嗪衍生物
WO2020227156A1 (en) * 2019-05-03 2020-11-12 Nektar Therapeutics Adenosine 2 receptor antagonists
EP4083044A4 (de) * 2019-12-26 2024-03-27 Zhejiang Vimgreen Pharmaceuticals, Ltd Verwendung von triazolotriazin-derivaten zur behandlung von krankheiten
EP4326724A4 (de) * 2021-04-23 2025-03-26 Chong Kun Dang Pharmaceutical Corp. Verbindung als adenosin-a2a-rezeptorantagonist und pharmazeutische zusammensetzung damit

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1264901B1 (it) 1993-06-29 1996-10-17 Schering Plough S P A Analoghi eterociclici di 1,2,4-triazolo(15-c)pirimidine ad attivita' antagonista per il recettore a2 dell'adenosina
ES2165393T3 (es) 1993-07-27 2002-03-16 Kyowa Hakko Kogyo Kk Remedio contra la enfermedad de parkinson.
IT1277392B1 (it) 1995-07-28 1997-11-10 Schering Plough S P A Analoghi eterociclici di 1,2,4-triazolo(1,5-c]pirimidine ad attivita' antagonista per il recettore a2a dell'adenosina
CA2284737C (en) * 1997-03-24 2007-03-13 Kyowa Hakko Kogyo Co., Ltd. [1,2,4]triazolo[1,5-c]pyrimidine derivatives
IT1291372B1 (it) 1997-05-21 1999-01-07 Schering Plough S P A Uso di analoghi eterociclici di 1,2,4-triazolo (1,5-c) pirimidine per la preparazione di medicamenti utili per il trattamento delle malattie
AU2639299A (en) 1998-02-24 1999-09-15 Kyowa Hakko Kogyo Co. Ltd. Remedies/preventives for parkinson's disease
HUP0103921A3 (en) * 1998-09-22 2002-12-28 Kyowa Hakko Kogyo Kk [1,2,4]triazolo[1,5-c]pyrimidine derivatives and pharmaceutical compositions thereof
US6355653B1 (en) 1999-09-06 2002-03-12 Hoffmann-La Roche Inc. Amino-triazolopyridine derivatives
JP2002037787A (ja) * 2000-05-16 2002-02-06 Kyowa Hakko Kogyo Co Ltd ［１，２，４］トリアゾロ［１，５−ｃ］ピリミジン誘導体の製造法
NZ522326A (en) 2000-05-26 2006-03-31 Schering Corp Adenosine A2A receptor antagonists
IL160878A0 (en) 2001-10-15 2004-08-31 Schering Corp Imidazo (4,3-e)-1,2,4-triazolo (1,5-c) pyrimidines as adenosine a2a receptor antagonists
IL161573A0 (en) * 2001-11-30 2004-09-27 Schering Corp [1,2,4]-TRIAZOLE BICYCLIC ADENOSINE A2a RECEPTOR ANTAGONISTS

Also Published As

Publication number Publication date
CA2468658C (en) 2009-04-14
ES2283625T3 (es) 2007-11-01
DE60219196D1 (de) 2007-05-10
WO2003048163A1 (en) 2003-06-12
HK1064097A1 (en) 2005-01-21
EP1453836B1 (de) 2007-03-28
IL161573A0 (en) 2004-09-27
JP4429724B2 (ja) 2010-03-10
HUP0402324A3 (en) 2008-09-29
US20030191130A1 (en) 2003-10-09
AR037681A1 (es) 2004-12-01
KR20050044600A (ko) 2005-05-12
TW200300689A (en) 2003-06-16
CN1688581A (zh) 2005-10-26
JP2010018634A (ja) 2010-01-28
DE60219196T2 (de) 2008-01-03
CA2468658A1 (en) 2003-06-12
JP2005511697A (ja) 2005-04-28
US6875772B2 (en) 2005-04-05
US7078408B2 (en) 2006-07-18
PE20030653A1 (es) 2003-08-04
EP1453836A1 (de) 2004-09-08
HUP0402324A2 (hu) 2005-02-28
US20050113380A1 (en) 2005-05-26
ZA200404168B (en) 2005-09-02
AU2002352933A1 (en) 2003-06-17
MXPA04005158A (es) 2004-08-11

Similar Documents

Publication Publication Date Title
ATE453647T1 (de) Adenosin a2a rezeptor antagonisten
ATE358130T1 (de) Bicyclische (1,2,4ö-triazol adenosin a2a rezeptor antagonisten
ATE293627T1 (de) Adenosin a2a rezeptor antagonisten
DE60209251D1 (de) Adenosine a2a receptor antagonisten
HUP0401925A3 (en) A2b adenosine receptor antagonists
PT1189916E (pt) N-pirazole agonistas do receptor a2a
ATE461932T1 (de) Pyrazoloä4,3-eü-1,2,4-triazoloä1,5-cüpyrimidine als antagonisten des adenosin-a2a-rezeptors
HUP0401437A3 (en) Adenosine a3 receptor agonists
NO20016351L (no) C-pyrazol A2A reseptoragonister
DE50208895D1 (de) Substituierte 2-thio-3, 5-dicyano-4-aryl-6-aminopyridine und ihre verwendung als adenosinrezeptor-selektive liganden
SMP200600024B (it) 2,6-Biseteroaril-4-amminopirimidine come antagonisti del recettore dell'adenosina
NO20034929L (no) 4-amino-5-fenyl-7-cyklobutylpyrrol(2,3-D)pyrimidinderivater
ATE242259T1 (de) Adenosin a1-rezeptor agonisten
ATE432282T1 (de) 2-alkinyl- und 2-alkenyl-pyrazolo-ä4,3-eü -1,2,4- triazolo-ä1,5-cü -pyrimidinadenosin a2a rezeptorantagonisten
PL373953A1 (en) 7-amino-benzothiazole derivatives as adenosine receptor ligands
ATE477800T1 (de) 2-aminocarbonlyl-chinolin-verbindungen als adenosin diphosphat plättchenrezeptor antagonisten
ATE394402T1 (de) Kondensierte purinderivate als a1- adenosinrezeptorantagonisten
PT1208100E (pt) Antagonistas selectivos de receptores de adenosina a2b
HRP20040672A2 (en) Triazolo-quinolin derivatives useful as adenosine receptor ligands
ATE338043T1 (de) 5-methoxy-8-aryl- 1,2,4ötriazolo 1,5-aöpyridine derivative als adenosin-rezeptor antagonisten
NO20033223L (no) Histamin-reseptor antagonister
DE60220713D1 (de) Ribofuranosyluronamid Derivate als Kristall; ein menschlicher Adenosin A2A Rezeptor Agonsit
HK1056359A (en) Purine derivatives as purinergic receptor antagonists

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties